Celgene Expands Relationship With Medidata In Enterprise Clinical Trial Technology
NEW YORK--(BUSINESS WIRE)--Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that Celgene Corporation has expanded its eight-year technology relationship with Medidata to add the Medidata Clinical Cloud® as its enterprise technology platform for all clinical trials worldwide.